Novanta Inc Stock Price, News & Analysis

Novanta reported Q1 2021 revenues of $162.6 million, a 4.6% increase year-over-year. Operating income declined to $11.1 million from $13.3 million, with net income at $11.3 million compared to $11.9 million in Q1 2020. Adjusted diluted EPS rose to $0.58 from $0.51. The company noted a 28% increase in bookings sequentially and 25% year-over-year, driven by strong demand in advanced industrial sectors. Guidance for Q2 forecasts revenue of $162 million to $165 million and for the full year expects revenue between $645 million to $655 million.

Novanta Inc. (Nasdaq: NOVT) will announce its Q1 2021 results on May 11, 2021, at 10:00 a.m. ET. Investors can join the conference call by dialing (888) 346-3959 or via a live webcast on the Company’s website. A replay of the call will be available approximately three hours post-call until July 5, 2021. Novanta is a global leader in core technology solutions, specializing in photonics, vision, and precision motion, aimed at enhancing the performance of healthcare and industrial OEMs.

Novanta Inc. (NASDAQ: NOVT) has announced that Matthijs Glastra will take on the role of Chairman of the Board effective after the Annual Meeting on May 13, 2021. He succeeds Stephen W. Bershad, who retires after 11 years of impactful leadership. Also, Lonny Carpenter will become the independent Lead Director. In recognition of Bershad’s contributions, he will be appointed Chairman Emeritus. Glastra noted that the company is well-positioned for sustained growth, despite challenges posed by the COVID-19 pandemic.

Novanta reported Q4 and full year 2020 results, highlighting revenue of $147.5 million, down 7.6% year-over-year. For the full year, revenue declined 5.7% to $590.6 million. Despite a decrease in organic growth of 10.1% for Q4, operating income rose to $17.1 million, and net income reached $12.7 million. Adjusted diluted EPS for Q4 was $0.53, slightly down from $0.55. The company forecasts Q1 2021 revenue of $155 million to $157 million and plans to launch significantly more new products. Operating cash flow remained strong at $46.6 million for Q4.

Novanta Inc. (Nasdaq: NOVT) will announce its fourth quarter and full year 2020 results on March 1, 2021. A conference call is scheduled for the same day at 10:00 a.m. ET, accessible via phone or through a live webcast on the Company's website. A replay of the call will be available approximately three hours after its conclusion, lasting until April 5, 2021. Novanta is a global supplier of advanced technology solutions that provide OEMs in healthcare and industrial sectors with a competitive edge through precision and technical expertise.

Novanta Inc. (Nasdaq:NOVT), a leader in technology solutions for medical and advanced industrial OEMs, announced that CEO Matthijs Glastra will present at the virtual J.P. Morgan Healthcare Conference on January 13, 2021. Novanta specializes in photonics, vision, and precision motion technologies, providing clients with high-performance sub-systems tailored to their requirements. The company's growth is driven by a team committed to innovation and customer success. For more information, visit www.novanta.com.

Novanta Inc. (Nasdaq: NOVT) announced that its CFO, Robert Buckley, will present at the CJS Securities 21st Annual New Ideas for the New Year Conference on January 13, 2021. Novanta specializes in technology solutions for medical and advanced industrial OEMs, leveraging expertise in photonics, vision, and precision motion. The company focuses on engineering high-performance components and subsystems tailored for demanding applications, contributing to its growth through innovation and customer success.

Novanta Inc. (NASDAQ: NOVT) reported third-quarter 2020 financial results, showing GAAP revenue of $142.9 million, down 7.2% from $154.1 million in Q3 2019. Operating income decreased to $11.9 million, and net income was $8.3 million, compared to $12.8 million and $8.9 million, respectively, in the prior year. Adjusted EBITDA was $30.2 million, slightly lower than $31.0 million in Q3 2019. The company generated significant operating cash flow of $42.1 million, up from $7.0 million last year. Novanta anticipates fourth-quarter revenue of $144-$149 million, with continued focus on product innovation.

Novanta Inc. (Nasdaq: NOVT) announces that CEO Matthijs Glastra and CFO Robert Buckley will present at the Baird Global Industrial Conference on November 11, 2020. The company is renowned for providing core technology solutions, enhancing the competitive edge of medical and industrial OEMs through expertise in photonics, vision, and precision motion. Novanta's common shares are listed on Nasdaq under the ticker symbol 'NOVT'. For more details, visit www.novanta.com.